-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation
-
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Interview: Clinical Investigation